ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
randomvirus
|
574 |
197K |
6 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
197K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
randomvirus
|
55 |
22K |
8 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
55
|
22K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
randomvirus
|
1.0K |
392K |
9 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
392K
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
randomvirus
|
618 |
238K |
1 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
618
|
238K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast First Quarter Financial Results Webcast
|
|
randomvirus
|
94 |
30K |
20 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
94
|
30K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast First Quarter Financial Results Webcast
|
|
randomvirus
|
94 |
30K |
22 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
94
|
30K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
randomvirus
|
321 |
103K |
4 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
321
|
103K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
randomvirus
|
373 |
88K |
30 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
373
|
88K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
randomvirus
|
408 |
124K |
33 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
408
|
124K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
randomvirus
|
340 |
113K |
1 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
340
|
113K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
randomvirus
|
340 |
113K |
9 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
340
|
113K
|
9
|
|
ASX - By Stock
|
SNT |
Re:
Ann: BTC: Exclusive distribution rights for Bronchitol & Aridol
|
|
randomvirus
|
9 |
3.1K |
3 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
9
|
3.1K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
randomvirus
|
422 |
145K |
19 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
422
|
145K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
randomvirus
|
17K |
6.7M |
3 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
randomvirus
|
272 |
138K |
16 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
272
|
138K
|
16
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Financial Results Half Year - Webinar Announcement
|
|
randomvirus
|
17 |
6.6K |
6 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
17
|
6.6K
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
randomvirus
|
10K |
3.0M |
2 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
randomvirus
|
1.1K |
313K |
14 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
1.1K
|
313K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
randomvirus
|
1.1K |
313K |
8 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
1.1K
|
313K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
randomvirus
|
17K |
6.7M |
0 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
17K
|
6.7M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
randomvirus
|
1.1K |
313K |
13 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
313K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update Webcast
|
|
randomvirus
|
49 |
13K |
4 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
49
|
13K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
randomvirus
|
763 |
324K |
7 |
12/01/21 |
12/01/21 |
ASX - By Stock
|
763
|
324K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO trading tonight
|
|
randomvirus
|
136 |
54K |
2 |
12/01/21 |
12/01/21 |
ASX - By Stock
|
136
|
54K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO trading tonight
|
|
randomvirus
|
136 |
54K |
0 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
136
|
54K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
randomvirus
|
763 |
324K |
4 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
randomvirus
|
763 |
324K |
29 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
randomvirus
|
183 |
94K |
85 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
183
|
94K
|
85
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
randomvirus
|
183 |
94K |
1 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
183
|
94K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
randomvirus
|
183 |
94K |
3 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
183
|
94K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
randomvirus
|
425 |
190K |
14 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
425
|
190K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
randomvirus
|
572 |
252K |
3 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
572
|
252K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update and Financial Results Webcast
|
|
randomvirus
|
51 |
19K |
14 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
51
|
19K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
randomvirus
|
811 |
334K |
52 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
811
|
334K
|
52
|
|
ASX - By Stock
|
MSB |
Re:
Regenerative Medicine and Cell Therapies Virtual Event
|
|
randomvirus
|
129 |
57K |
6 |
19/09/20 |
19/09/20 |
ASX - By Stock
|
129
|
57K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
clinicaltrials.gov - MSCs in COVID-19 ARDS
|
|
randomvirus
|
199 |
93K |
26 |
19/09/20 |
19/09/20 |
ASX - By Stock
|
199
|
93K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
randomvirus
|
13K |
5.0M |
3 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
randomvirus
|
3.1K |
1.4M |
41 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
41
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
randomvirus
|
3.1K |
1.4M |
6 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
randomvirus
|
3.1K |
1.4M |
50 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
50
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
randomvirus
|
3.1K |
1.4M |
1 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
randomvirus
|
3.1K |
1.4M |
38 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
38
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
randomvirus
|
5.4K |
2.7M |
2 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
5.4K
|
2.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
10 Sept 12pm NSW Stem Cell Network - Stem Cells vs COVID19
|
|
randomvirus
|
220 |
84K |
1 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
220
|
84K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
10 Sept 12pm NSW Stem Cell Network - Stem Cells vs COVID19
|
|
randomvirus
|
220 |
84K |
1 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
220
|
84K
|
1
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Update on the Gold Sludge held at the Chatree Gold Mine
|
|
randomvirus
|
55 |
18K |
1 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
55
|
18K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
randomvirus
|
3.1K |
1.4M |
1 |
01/09/20 |
01/09/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
randomvirus
|
3.1K |
1.4M |
1 |
29/08/20 |
29/08/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2020 Full Year Financial Results Webcast
|
|
randomvirus
|
71 |
33K |
9 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
71
|
33K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2020 Full Year Financial Results Webcast
|
|
randomvirus
|
71 |
33K |
3 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
71
|
33K
|
3
|
|